Psychiatry and Neurology, Neurology · Dallas, TX
NPI
1013064435
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
3600 Gaston Ave, Suite 1155
Dallas, TX, 75246
Phone (214) 820-4688
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
1,279 services
Medicare patients, 2024
533
Average age 73
Drug cost, 2024
$2.0M
4,037 prescriptions
Company payments, 2025
$2,936
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sadat A Shamim was code 99424 (chronic, principal, and transitional care management), 233 times for 179 patients. In total Sadat A Shamim billed 1,279 services in 34 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99424 Chronic, Principal, and Transitional Care Management | Office | 233 | 179 | $58.15 | $14K |
| 99423 E&M - Miscellaneous | Office | 159 | 132 | $31.72 | $5,043 |
| 36415 Venipuncture Blood Collection | Office | 154 | 141 | $8.60 | $1,324 |
| 95816 Neurologic | Facility | 100 | 95 | $41.30 | $4,130 |
| 95720 Neurologic | Facility | 76 | 48 | $157.64 | $12K |
| 99204 Office E&M - New | Office | 61 | 61 | $125.87 | $7,678 |
| 99213 Office E&M - Established | Office | 54 | 50 | $64.82 | $3,500 |
| 99443 Telephone Services | Office | 38 | 30 | $80.64 | $3,064 |
| 95718 Neurologic | Facility | 28 | 22 | $101.78 | $2,850 |
| 95822 Neurologic | Facility | 27 | 26 | $43.58 | $1,177 |
| 99203 Office E&M - New | Office | 24 | 24 | $83.71 | $2,009 |
| 95819 Neurologic | Facility | 21 | 21 | $43.75 | $919 |
| 99205 Office E&M - New | Office | 20 | 20 | $155.47 | $3,109 |
| 99442 Telephone Services | Office | 15 | 13 | $63.89 | $958 |
| 99422 Office/Outpatient Services | Office | 14 | 13 | $21.26 | $298 |
By year: 2022 $92K for 2,111 services; 2023 $75K for 1,772 services; 2024 $68K for 1,279 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 154 | 141 | $8.60 | $1,324 |
Medicare prescription drug claims, 2024
In 2024, the drug Sadat A Shamim prescribed most often to Medicare patients was Levetiracetam, with 427 prescriptions and refills. In total Sadat A Shamim wrote 4,037 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 427 | 1,131 | 122 | $19K |
| Gabapentin Generic | 357 | 865 | 102 | $10K |
| Lamotrigine Generic | 267 | 680 | 68 | $6,856 |
| Donepezil Hcl Generic | 207 | 589 | 72 | $2,451 |
| Clonazepam Generic | 182 | 203 | 40 | $1,753 |
| Pregabalin Generic | 159 | 224 | 27 | $4,616 |
| Memantine Hcl Generic | 147 | 389 | 50 | $4,519 |
| Sertraline Hcl Generic | 133 | 322 | 37 | $1,411 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 116 | 310 | 36 | $3,001 |
| Topiramate Generic | 113 | 317 | 34 | $1,698 |
| Zonisamide Generic | 109 | 239 | 22 | $5,555 |
| Escitalopram Oxalate Generic | 88 | 213 | 29 | $884 |
| Oxcarbazepine Generic | 88 | 240 | 22 | $11K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 78 | 201 | 22 | $7,857 |
| Lacosamide Generic | 62 | 101 | 13 | $14K |
Brand drugs: 469 claims; generic drugs: 3,551 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sadat A Shamim $2,936 ($2,936 in general payments such as food, travel and fees) from 25 companies. The largest payer was UCB, Inc. with $600.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 27 | $600 |
| Abbvie Inc. ABBV | 32 | $570 |
| ACADIA Pharmaceuticals Inc ACAD | 15 | $261 |
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $195 |
| Pfizer Inc. PFE | 11 | $162 |
| Jazz Pharmaceuticals Inc. JAZZ | 5 | $152 |
| Argenx US, Inc. ARGX | 4 | $136 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $105 |
| Lilly USA, LLC LLY | 4 | $85.91 |
| MDD US Operations, LLC | 4 | $83.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.